文献速递其他结缔组织病

布鲁顿酪氨酸激酶基因过表达与原发性干燥综合征淋巴瘤风险的关联

Association Between Bruton's Tyrosine Kinase Gene Overexpression and Risk of Lymphoma in Primary Sjögren's Syndrome.
PubMed 文献 · Arthritis Rheumatol · 2023-07-28

该研究对ASSESS前瞻性队列中345例表型明确的原发性干燥综合征患者的外周血进行转录组分析,其中21例发生原发性干燥综合征相关非霍奇金淋巴瘤。结果发现,在淋巴瘤发生前,布鲁顿酪氨酸激酶(BTK)和增殖诱导配体(APRIL)基因在 incident 淋巴瘤患者中过表达,且BTK在多变量分析中与淋巴瘤风险相关,但作者指出该关联需在其他前瞻性队列中确认。

要点

  • 在 incident 原发性干燥综合征相关淋巴瘤患者中,淋巴瘤发生前外周血BTK和APRIL基因过表达。
  • 敏感性分析中,BTK在所有比较中均持续上调。
  • 多变量分析(纳入9个已验证的淋巴瘤预测因素)显示BTK表达与淋巴瘤风险相关。

核心结论

  • BTK和APRIL在原发性干燥综合征患者淋巴瘤发生前的外周血中过表达,BTK与淋巴瘤风险的关联需在其他前瞻性队列中确认。

研究设计与样本

  • 前瞻性ASSESS队列中345例表型明确的原发性干燥综合征患者,采集外周血并用Human Clariom S Arrays(Affymetrix)进行转录组分析。

主要发现

  • 21例原发性干燥综合征相关非霍奇金淋巴瘤患者(包括8例 incident 和13例既往淋巴瘤)纳入转录组分析,与324例无淋巴瘤的原发性干燥综合征对照比较。
  • 功能聚类分析显示先天性和适应性免疫相关基因富集,包括B细胞相关基因。
  • 在 incident 淋巴瘤患者中,淋巴瘤发生前BTK和APRIL基因相较于无淋巴瘤患者过表达。
  • 敏感性分析中,BTK在所有比较中持续上调。
  • 多变量分析(考虑9个已验证的原发性干燥综合征淋巴瘤预测因素)显示BTK表达与淋巴瘤风险相关。

局限性

  • 作者指出BTK、APRIL与原发性干燥综合征相关非霍奇金淋巴瘤的关联需在其他前瞻性队列中确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We undertook this study to analyze whole blood gene expression and to investigate the role of B cell genes in primary Sjögren's syndrome-related non-Hodgkin lymphoma (primary SS-NHL). METHODS: Peripheral whole blood samples were collected from 345 well-phenotyped patients with primary SS enrolled in the prospective Assessment of Systemic Signs and Evolution in Sjögren's Syndrome (ASSESS) cohort. Transcriptomic analysis was performed using human Clariom S Arrays (Affymetrix). In our primary analysis, we considered patients with incident lymphoma (i-primary SS-NHL) as the case group and all patients without lymphoma as the comparison group. In our sensitivity analyses, we considered all patients with primary SS-NHL, including those with a history of lymphoma (h-primary SS-NHL), as the case group and primary SS patients without lymphoma, stratified on their risk factors of lymphoma, as the comparison group. RESULTS: Twenty-one patients with primary SS-NHL (including 8 with i-primary SS-NHL and 13 h-primary SS-NHL) were eligible for transcriptomic analysis; we compared these patients to 324 primary SS controls without lymphoma, including 110 with moderate to severe disease activity and 61 with no risk factor of lymphoma. Functional clustering analyses revealed an enrichment of genes related to innate and adaptive immunity, including B cell-related genes. Bruton's tyrosine kinase (BTK) and a proliferation-inducing ligand (APRIL) genes were overexpressed before the occurrence of lymphoma in patients with incident lymphoma compared with patients without lymphoma. In sensitivity analyses, BTK was consistently up-regulated across all comparisons performed. BTK expression was associated with risk of lymphoma on multivariate analyses, which considered 9 validated predictors of lymphoma in primary SS. CONCLUSION: BTK and APRIL were overexpressed in the peripheral blood of primary SS patients prior to lymphoma. The association between BTK, APRIL, and primary SS-NHL requires confirmation in other prospective cohorts.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Duret PM, Schleiss C, Kawka L, et al. Association Between Bruton's Tyrosine Kinase Gene Overexpression and Risk of Lymphoma in Primary Sjögren's Syndrome. Arthritis Rheumatol. 2023. PMID: 37115807. doi:10.1002/art.42550

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。